Lin Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Lin Zhang has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Daiming Fan
State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi’an, China
1 shared publication Demiao Ma
College of Chemistry, Zhengzhou University, Zhengzhou 450001, P. R. China
1 shared publication- Fei Wang
Division of Digestive Surgery, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, 127 West Changle Road, Xi'an, 710032, Shaanxi, China
1 shared publication - Fei Wu
Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, P.R. China
1 shared publication - Fenli Zhou
State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases Fourth Military Medical University Xi'an PR China
1 shared publication - Guangheng Li
Division of Adult Joint Reconstruction and Sports Medicine, Department of Orthopedic Surgery, Shenzhen Key Laboratory of Musculoskeletal Tissue Reconstruction and Function Restoration, Shenzhen People's Hospital (the First Affiliated Hospital, Southern University of Science and Technology, The Second Clinical Medical College, Jinan University), Shenzhen, China
1 shared publication
Latest Publications
- Open Access
- 27 January 2025
- Published by Wiley in The Journal of Pathology: Clinical Research
- Vol. 11 (1) , e70015
Platinum drugs upregulate CXCR4 and PD‐L1 expression via ROS‐dependent pathways, with implications for novel combined treatment in gastric cancer
CXC chemokine receptor 4 (CXCR4) and programmed cell death‐ligand 1 (PD‐L1) are two critical molecules involved in the tumor immune microenvironment. However, the impact of platinum drugs, such as cisplatin, on CXCR4 or PD‐L1 expression and the underlying mechanisms in gastric cancer (GC) remain unknown. Moreover, the correlation between their expression levels in GC remains elusive. Immunohistochemistry, western blot, and RT‐qPCR were performed to determine the expression pattern of CXCR4 and PD‐L1 in GC. Clinical samples, patient‐derived xenografts, and cell‐derived xenografts were utilized to investigate the effects of platinum drugs on the expression levels of CXCR4 and PD‐L1. Postchemotherapy resected GC tumor tissues showed higher CXCR4 and PD‐L1 expression levels than pretreatment biopsies (p < 0.05). Similarly, GC xenografts treated with platinum‐based chemotherapy exhibited increased CXCR4 and PD‐L1 expression levels compared to saline‐treated controls (p < 0.05). A positive correlation was detected between the expression levels of CXCR4 and PD‐L1 in GC tumor tissues. Increased levels of CXCR4 and PD‐L1 expression, in a dose‐ and time‐dependent manner upon cisplatin treatment, were observed in GC cells (p < 0.05). Cisplatin‐induced CXCR4 upregulation relies on ROS/HIF‐1α and ROS/NF‐κB pathways, while cisplatin‐induced PD‐L1 upregulation is cyclic GMP‐AMP synthase/stimulator of IFN genes‐dependent and associated with elevated ROS levels in GC cells. CXCR4 expression was found to be positively correlated with PD‐L1 expression in GC. Platinum drugs upregulated the levels of CXCR4 and PD‐L1 expression in GC. A combined strategy targeting CXCR‐4 and PD‐L1 might have clinical prospects for GC patients.
- 27 January 2025
- Published by Wiley in The Journal of Pathology: Clinical Research
- Vol. 11 (1) , e70015
Open AccessPlatinum drugs upregulate CXCR4 and PD‐L1 expression via ROS‐dependent pathways, with implications for novel combined treatment in gastric cancer
CXC chemokine receptor 4 (CXCR4) and programmed cell death‐ligand 1 (PD‐L1) are two critical molecules involved in the tumor immune microenvironment. However, the impact of platinum drugs, such as cisplatin, on CXCR4 or PD‐L1 expression and the underlying mechanisms in gastric cancer (GC) remain unknown. Moreover, the correlation between their expression levels in GC remains elusive. Immunohistochemistry, western blot, and RT‐qPCR were performed to determine the expression pattern of CXCR4 and PD‐L1 in GC. Clinical samples, patient‐derived xenografts, and cell‐derived xenografts were utilized to investigate the effects of platinum drugs on the expression levels of CXCR4 and PD‐L1. Postchemotherapy resected GC tumor tissues showed higher CXCR4 and PD‐L1 expression levels than pretreatment biopsies (p < 0.05). Similarly, GC xenografts treated with platinum‐based chemotherapy exhibited increased CXCR4 and PD‐L1 expression levels compared to saline‐treated controls (p < 0.05). A positive correlation was detected between the expression levels of CXCR4 and PD‐L1 in GC tumor tissues. Increased levels of CXCR4 and PD‐L1 expression, in a dose‐ and time‐dependent manner upon cisplatin treatment, were observed in GC cells (p < 0.05). Cisplatin‐induced CXCR4 upregulation relies on ROS/HIF‐1α and ROS/NF‐κB pathways, while cisplatin‐induced PD‐L1 upregulation is cyclic GMP‐AMP synthase/stimulator of IFN genes‐dependent and associated with elevated ROS levels in GC cells. CXCR4 expression was found to be positively correlated with PD‐L1 expression in GC. Platinum drugs upregulated the levels of CXCR4 and PD‐L1 expression in GC. A combined strategy targeting CXCR‐4 and PD‐L1 might have clinical prospects for GC patients.
- Open Access
- 28 September 2023
- Published by Integrative Nursing Press in Chinese Journal of Integrative Nursing
- Vol. 9 (9) , 129-135
Clinical practice and research progress of Traditional Chinese Medicine nursing of neurogenic cervical spondylosis
- 28 September 2023
- Published by Integrative Nursing Press in Chinese Journal of Integrative Nursing
- Vol. 9 (9) , 129-135
Open AccessClinical practice and research progress of Traditional Chinese Medicine nursing of neurogenic cervical spondylosis
- 26 September 2022
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 5 (10) , 14602-14608
Concatenated DNA Circuit-Assembled DNAzyme as an Amplified Quencher for MicroRNA Detection
- 26 September 2022
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 5 (10) , 14602-14608
Concatenated DNA Circuit-Assembled DNAzyme as an Amplified Quencher for MicroRNA Detection
- 1 December 2020
- Published by Elsevier in Synthetic Metals
- Vol. 270, 116580
Controllable and fast growth of ultrathin α-Ni(OH)2 nanosheets on polydopamine based N-doped carbon spheres for supercapacitors application
- 1 December 2020
- Published by Elsevier in Synthetic Metals
- Vol. 270, 116580
Controllable and fast growth of ultrathin α-Ni(OH)2 nanosheets on polydopamine based N-doped carbon spheres for supercapacitors application